Q Biomed inc (QBIO) Annual Balance Sheets

Annual · GAAP · USD millions
Access QBIO quarterly Balance Sheets →
Looking at balance sheet data from Q Biomed inc through Nov 30 2017 provides insight into Nov 30 2022's solvency and capital structure over time.
Annual Report, GAAP in USD millions
ITEM
(Nov 30 2022)
(Nov 30 2021) (Nov 30 2019) (Nov 30 2018) (Nov 30 2017)
Assets
Cash & cash equivalent0.05
Cash & Short-term Investments0.00
Accounts receivable0.01
Other Current Assets0.00
Prepaid Expense And Other Assets Current0.01
Total Current Assets0.07
Intangible Assets0.30
Long-term investments3.14
Other Assets, Noncurrent3.14
Total Assets3.52
Liabilities
Accounts Payable, Current AC2.13
Accrued Liabilities, Current1.55
Derivative Liability, Current DE0.09
Debt, Current LI4.11
Other Liabilities, Current0.25
Total Current Liabilities8.13
Long-term debt0.00
Convertible Notes Payable NO0.00
Total Long-term Debt0.00
Other liabilities, Noncurrent0.00
Total Liabilities8.13
Stockholders' Equity
Common Stock Value0.08
Additional Paid In Capital Common Stock56.31
Retained Earnings / Accumulated Deficit-66.10
Other Equity5.09
Common Stockholder's Equity-4.62
Total Stockholder's Equity-4.62
Liabilities & Stockholder's Equity3.52
4 historic quarters locked

Sign in to unlock the full Q Biomed inc balance sheet history.

About Q Biomed Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001410578-23-001458

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License